Menopause and Cancers

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Cancer is a disease of aging, and therefore is more prevalent after menopause. Menopausal symptoms resulting from cancer treatments are an important survivorship issue in cancer care. This article reviews the preventive strategies, utilization of health resources, and management of menopausal symptoms after cancer treatment. Preventive screening as informed by genetic and lifestyle risk, and lifestyle modification, may mitigate the risk of cancer and cancer mortality. Despite potential benefits to quality of life, hormone replacement is rarely prescribed to survivors of gynecologic malignancies. Special considerations are needed for the treatment and supportive care of menopausal symptoms in cancer survivors.

Original languageEnglish (US)
Pages (from-to)603-617
Number of pages15
JournalEndocrinology and Metabolism Clinics of North America
Volume44
Issue number3
DOIs
StatePublished - Sep 1 2015

Fingerprint

Menopause
Neoplasms
Survivors
Life Style
Health Resources
Therapeutics
Survival Rate
Quality of Life
Hormones
Mortality

Keywords

  • Cancer
  • Cancer prevention
  • Cancer screening
  • Hormone replacement
  • Lifestyle modification
  • Menopause

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Menopause and Cancers. / Einstein, Mark H.; Levine, Nanci; Nevadunsky, Nicole S.

In: Endocrinology and Metabolism Clinics of North America, Vol. 44, No. 3, 01.09.2015, p. 603-617.

Research output: Contribution to journalArticle

@article{e696aa9ab32140279b662c048b6518da,
title = "Menopause and Cancers",
abstract = "Cancer is a disease of aging, and therefore is more prevalent after menopause. Menopausal symptoms resulting from cancer treatments are an important survivorship issue in cancer care. This article reviews the preventive strategies, utilization of health resources, and management of menopausal symptoms after cancer treatment. Preventive screening as informed by genetic and lifestyle risk, and lifestyle modification, may mitigate the risk of cancer and cancer mortality. Despite potential benefits to quality of life, hormone replacement is rarely prescribed to survivors of gynecologic malignancies. Special considerations are needed for the treatment and supportive care of menopausal symptoms in cancer survivors.",
keywords = "Cancer, Cancer prevention, Cancer screening, Hormone replacement, Lifestyle modification, Menopause",
author = "Einstein, {Mark H.} and Nanci Levine and Nevadunsky, {Nicole S.}",
year = "2015",
month = "9",
day = "1",
doi = "10.1016/j.ecl.2015.05.012",
language = "English (US)",
volume = "44",
pages = "603--617",
journal = "Endocrinology and Metabolism Clinics of North America",
issn = "0889-8529",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Menopause and Cancers

AU - Einstein, Mark H.

AU - Levine, Nanci

AU - Nevadunsky, Nicole S.

PY - 2015/9/1

Y1 - 2015/9/1

N2 - Cancer is a disease of aging, and therefore is more prevalent after menopause. Menopausal symptoms resulting from cancer treatments are an important survivorship issue in cancer care. This article reviews the preventive strategies, utilization of health resources, and management of menopausal symptoms after cancer treatment. Preventive screening as informed by genetic and lifestyle risk, and lifestyle modification, may mitigate the risk of cancer and cancer mortality. Despite potential benefits to quality of life, hormone replacement is rarely prescribed to survivors of gynecologic malignancies. Special considerations are needed for the treatment and supportive care of menopausal symptoms in cancer survivors.

AB - Cancer is a disease of aging, and therefore is more prevalent after menopause. Menopausal symptoms resulting from cancer treatments are an important survivorship issue in cancer care. This article reviews the preventive strategies, utilization of health resources, and management of menopausal symptoms after cancer treatment. Preventive screening as informed by genetic and lifestyle risk, and lifestyle modification, may mitigate the risk of cancer and cancer mortality. Despite potential benefits to quality of life, hormone replacement is rarely prescribed to survivors of gynecologic malignancies. Special considerations are needed for the treatment and supportive care of menopausal symptoms in cancer survivors.

KW - Cancer

KW - Cancer prevention

KW - Cancer screening

KW - Hormone replacement

KW - Lifestyle modification

KW - Menopause

UR - http://www.scopus.com/inward/record.url?scp=84940451829&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940451829&partnerID=8YFLogxK

U2 - 10.1016/j.ecl.2015.05.012

DO - 10.1016/j.ecl.2015.05.012

M3 - Article

VL - 44

SP - 603

EP - 617

JO - Endocrinology and Metabolism Clinics of North America

JF - Endocrinology and Metabolism Clinics of North America

SN - 0889-8529

IS - 3

ER -